News
03-14-2010, 04:04 AM
Pfizer Inc. announced today that two Phase 3 studies of Sutent® (sunitinib malate) in advanced breast cancer did not meet their primary endpoints...
More... (http://mnt.to/f/3ySr)
More... (http://mnt.to/f/3ySr)
View Full Version : Two Phase 3 Trials Of Sunitinib With Commonly Used Chemotherapies In Advanced Breast